10/19/2026
Danny Malone returns with 'Burning Hills' after ibogaine treatment
Singer-songwriter Danny Malone's new album follows recovery from addiction with ibogaine therapy.
Topic archive
texas
37 stories
10/16/2026
Danny Malone returns with 'Burning Hills' after decade-long hiatus
Malone's new song marks a comeback after battling addiction and personal loss.
10/16/2026
Empire unveils Dune: Part Three covers with scientific themes
Dune: Part Three explores complex scientific ideas, including ibogaine's potential.
10/14/2026
Ibogaine's potential in addiction treatment faces cardiac risks
New review highlights ibogaine's promise and dangers in addiction therapy.
10/10/2026
Black Betty Mustang auction to benefit ibogaine research
Proceeds from the auction will support Americans for Ibogaine's efforts to mainstream ibogaine treatment.
10/10/2026
Navy SEAL's ibogaine experience highlights risks
Shawn Ryan's story underscores the dangers of seeking healing through psychedelics.
10/9/2026
FDA seeks input on ibogaine trials amid safety concerns
FDA's request for ibogaine trial proposals highlights cardiac risks and regulatory challenges.
10/9/2026
Ibogaine shows promise for PTSD in veterans, Stanford study finds
A year-long study suggests ibogaine may help veterans with PTSD, but more research is needed.
10/9/2026
FDA faces internal dissent over HHS peptide legalization
HHS plans to allow unapproved peptides, sparking FDA staff concerns.
10/8/2026
Texas ibogaine trials face funding gap as federal support looms
Federal funds may replace private investment in Texas ibogaine research
10/7/2026
FDA proposes strict ibogaine trial guidelines
Public input sought on inpatient care and heart monitoring
10/5/2026
Psyence BioMed to manufacture ibogaine in Texas with Benuvia
Psyence BioMed partners with Benuvia for U.S. ibogaine production, aiming to advance clinical research.
10/5/2026
Psyence BioMed partners with Benuvia for ibogaine production
Agreement aims to produce pharmaceutical-grade ibogaine in Texas facility.
10/1/2026
Gabon seeks fair share from ibogaine boom
New decree aims to ensure benefit sharing from ibogaine's global trade.
9/28/2026
Psyence Biomedical secures $1.3M ibogaine licensing deal
Texas subsidiary gains exclusive U.S. rights to PsyLabs' ibogaine
9/28/2026
Psyence secures exclusive U.S. ibogaine license
Texas subsidiary gains rights to ibogaine hydrochloride for drug development.
9/23/2026
Psyence BioMed announces ibogaine investment and trial plans
Psyence BioMed to invest $5M in PsyLabs, plans Texas ibogaine trial.
9/23/2026
Psyence Biomedical expands with Texas ibogaine unit
Company invests $5 million in PsyLabs for ibogaine research and production.
9/23/2026
Psyence BioMed invests $5M in PsyLabs for U.S. ibogaine program
Investment aims to bolster ibogaine research for opioid use disorder in Texas.
9/23/2026
Ibogaine under scrutiny after Presley Gerber's death
No link established between ibogaine and Gerber's death, but heart risks persist.
9/23/2026
Psyence and PsyLabs share exchange to boost ibogaine research
Psyence and PsyLabs collaborate to advance ibogaine for opioid use disorder.
9/14/2026
Psyence BioMed forms Texas entity for U.S. ibogaine research
Texas Ibogaine Research Corporation to spearhead U.S. ibogaine development efforts.
9/1/2026
Barrow, ASU launch clinical trial for ibogaine in the US
The study aims to explore ibogaine's potential for treating PTSD and addiction.
8/19/2026
Psyence BioMed supports U.S. push for ibogaine development
U.S. federal actions could accelerate ibogaine's medical potential
8/19/2026
Psyence BioMed backs Trump ibogaine initiative
Company aligns with U.S. efforts to advance ibogaine research.
8/10/2026
Barrow Neurological Institute secures $5M for ibogaine brain injury trial
Arizona funds first U.S. ibogaine trial for traumatic brain injuries, starting 2027.
8/7/2026
Ibogaine gains traction among conservative leaders
Rick Perry and Bryan Hubbard lead efforts to legitimize ibogaine in Texas.
8/7/2026
Arizona funds $5M ibogaine trial for brain injury
Study explores ibogaine's potential for TBI, amid safety concerns and federal illegality.
7/29/2026
Texas initiates ibogaine research with federal support
State-led ibogaine study in Texas receives federal funding, advancing research into opioid treatment.
7/29/2026
Texas initiates ibogaine research with federal support
State-led ibogaine study in Texas gains federal backing, marking a significant research development.
7/29/2026
Texas begins state-led ibogaine research with federal support
The new program aims to explore ibogaine's potential in treating opioid addiction.
7/27/2026
Ibogaine treatment provision included in defense bill
New NDAA provision aims to expand ibogaine access for veterans.
7/22/2026
McCaul advocates for ibogaine access for veterans
Proposed NDAA amendment aims to expand treatment options for PTSD and TBI.
7/16/2026
San Antonio mayor advocates for ibogaine trials
Mayor Gina Ortiz Jones pushes for psychedelic trials to aid veterans.
7/16/2026
Texas leaders advocate ibogaine research
Veterans report transformative effects from psychedelic treatment.
7/16/2026
Texas leaders advocate ibogaine research
Veterans report transformative effects from psychedelic therapy.
7/16/2026
Texas leaders advocate for ibogaine research
Veterans share recovery stories, highlighting ibogaine's potential.